|Oncology:||Focus on tumor cell proliferation, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, cancer immunotherap and Antibody Drug Conjugates (ADC) as well as Targeted Thorium Conjugates (TTC).|
|Gynecology：||Focus on novel treatment options for endometriosis (incl. adenomyosis uteri /endometriosis interna), uterine fibroids (uterine leiomyoma) and polycystic ovary syndrome (PCOS)|
|Cardiology：||Focus on novel approaches to the care of chronic and/or acute pulmonary hypertension & adjacent lung indications, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and including kidney and lung diseases.|
|Hematology：||Focus on novel, innovative targets for hemophilia.|
To further advance research on targets that are at a very early stage of discovery; fixed grant approval letter; IP rights remain with the applicant.
For more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; fixed grant approval letter; IP rights remain with the applicant.
(External website “Grants4Targets”)